• Noela Carrera-Guermeur, Rosa M Martín-Crespo, Hilda J Ramírez, Ángel Pantoja, and Rafael Luque-Mialdea.
• Department of Pediatric Surgery, Complejo Hospitalario de Toledo, Avenida de Barber, No 30, 45004, Toledo, Spain. noelacarrera@hotmail.com.
• Eur. J. Pediatr. 2016 Mar 1; 175 (3): 305-12.

UnlabelledEnterocutaneous fistula and its conservative management still pose a challenge for the surgeon. The use of octreotide and somatostatin in neonates and children as adjunctive therapy in the conservative management of this condition, leads to major controversy regarding its efficacy. Therefore, we conducted an extensive literature review of published articles regarding the use of somatostatin and its analogues in the treatment of enterocutaneous fistula in neonates and children. Our review is then presented together with a case vignette and discusses the different practical aspects of the treatment with these drugs.ConclusionThe major diversity in treatment regimens among published studies makes outcomes difficult to compare. However, given the results of the different cases reported in the literature and of our own experience, we suggest a possible beneficial effect of octreotide and somatostatin on closure of enterocutaneous fistula in these patients.

21 keywords...

hide…